The laser and machine tool manufacturer successfully achieved a further increase in profits. Income before taxes rose by 43.8 percent to €357 million, while the net operating margin was 13.1 percent.

This growth is due in part to a one-off effect from the sale of the company's medical technology division, effective August 1, 2014, which positively impacted the result by an additional €72 million. Adjusted for this effect, the net operating margin improved from 9.6 to 10.5 percent.

Trumpf also boosted its sales despite the discontinuation of the medical technology division, consolidated sales increased in relation to the previous year by 5.0 percent to €2.72 billion – so Trumpf actually managed to overcompensate for the €184 million contributed by the medical technology companies during the 2013/14 fiscal year. In an annual comparison adjusted for the medical technology factor, revenues increased by 12.6 percent.

There was a further shift in regional sales distribution. Germany still remained the largest single market, but on a slightly declining trend. Behind it, the United States and China switched places, and China became Trumpf 's largest foreign market for the first time. Trumpf registered good gains in Western Europe, especially in France and Italy.

"In the final analysis, our strategy of growth through innovation, regional diversification and targeted acquisitions in our core business has been a successful one," said Trumpf President Dr. Nicola Leibinger-Kammüller. The overall number of employees – 10,873 as of June 30, 2015 – remained at the level of the previous year. The research and development ratio in relation to sales stood at 9.8 percent.